Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 31–45 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2968 BMPR1B Gene Sequencing (NGS) Test This test evaluates the BMPR1B gene for pathogenic variants associated with acromesomelic chondrodysplasia with genital anomalies (AMCD2B).	Whole Blood (EDTA) or Buccal Swab	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMPR1B gene coding region variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected acromesomelic chondrodysplasia with genital anomalies (AMCD2B)", "Genetic counselling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82394-1 ICD-10: Q77.8 Clinical summary This test evaluates the BMPR1B gene for pathogenic variants associated with acromesomelic chondrodysplasia with genital anomalies (AMCD2B).
TEST-3963 BMPR2 Gene Pulmonary Veno-Occlusive Disease Type 1 Genetic Test This test evaluates the BMPR2 gene for pathogenic variants associated with pulmonary veno-occlusive disease and heritable pulmonary arterial hypertension.	Whole Blood, DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BMPR2 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (Indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of current medications, especially anticoagulants"] Indications ["Diagnosis of pulmonary veno-occlusive disease (PVOD)", "Diagnosis of heritable pulmonary arterial hypertension (HPAH)", "Familial risk assessment for PVOD/HPAH", "Cascade testing in families with known BMPR2 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 48002-0 ICD-10: I27.0, I27.20, Z15.09 Clinical summary This test evaluates the BMPR2 gene for pathogenic variants associated with pulmonary veno-occlusive disease and heritable pulmonary arterial hypertension.
TEST-4387 BSCL2 (Seipin) Gene Progressive Encephalopathy with or without Lipodystrophy Genetic Test This genetic test evaluates the BSCL2 gene for mutations associated with progressive encephalopathy and congenital generalised lipodystrophy type 2.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in BSCL2 gene", "Small insertions or deletions in BSCL2 gene", "Copy number variations (CNVs) in BSCL2 gene"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session required"] Indications ["Suspected diagnosis of progressive encephalopathy", "Suspected diagnosis of congenital generalised lipodystrophy type 2 (CGL2)", "Family history of BSCL2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94800-0 ICD-10: G31.89, E88.1 Clinical summary This genetic test evaluates the BSCL2 gene for mutations associated with progressive encephalopathy and congenital generalised lipodystrophy type 2.
TEST-5308 C19orf12 Gene Genetic Test for NBIA4/MPAN This test evaluates the C19orf12 gene for pathogenic variants associated with Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA4/MPAN). It identifies specific genetic mut...	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C19orf12 gene", "Copy Number Variations (CNVs) in C19orf12"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Completed pedigree chart required"] Indications ["Confirming clinical diagnosis of NBIA4/MPAN", "Guiding family risk assessment", "Assessing carrier status in relatives"] Measurement technique Confirm with laboratory Codes LOINC: 55251-0 ICD-10: G23.0 Clinical summary This test evaluates the C19orf12 gene for pathogenic variants associated with Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA4/MPAN). It identifies specific genetic mutations linked to this neurodegenerative disorder.
TEST-5299 C7 Gene Deficiency Genetic Test This test identifies pathogenic variants in the C7 gene associated with hereditary complement component 7 deficiency.	Whole Blood (EDTA tube) or FTA Card (Dried Blood Spot)	14–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C7 gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["None specified"] Indications ["Suspected hereditary complement component 7 deficiency", "Family history of C7 deficiency", "Recurrent severe infections"] Measurement technique Confirm with laboratory Codes LOINC: 95275-6 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C7 gene associated with hereditary complement component 7 deficiency.
TEST-3886 C7orf43 Gene Autism Genetic Test This test evaluates the C7orf43 gene for pathogenic variants associated with autism spectrum disorder.	Venous Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C7orf43 gene", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Detailed clinical history and pedigree chart needed"] Indications ["Diagnosis of autism spectrum disorder", "Identification of genetic factors contributing to neurodevelopmental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: F84.0 Clinical summary This test evaluates the C7orf43 gene for pathogenic variants associated with autism spectrum disorder.
TEST-4254 CACNA1B (DYT23) Gene NGS Test This test analyzes the CACNA1B gene for pathogenic variants associated with DYT23, an early-onset isolated dystonia.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1B gene", "Single nucleotide variants", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected DYT23 dystonia", "Early-onset isolated dystonia", "Family history of dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 94705-0 ICD-10: G24.1 Clinical summary This test analyzes the CACNA1B gene for pathogenic variants associated with DYT23, an early-onset isolated dystonia.
TEST-4106 CACNA1D Gene Sequencing Test (Sinoatrial Node Dysfunction & Deafness) This test evaluates the CACNA1D gene for pathogenic variants associated with sinoatrial node dysfunction and deafness (SANDD). It identifies genetic mutations linked to specific ca...	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "Single nucleotide variants", "Small insertions/deletions", "Deep intronic mutations"] Parameters [] Preparation ["Do not discontinue prescribed cardiac medications or hearing loss therapies without consulting your physician."] Indications ["Patients with unexplained slow heart rate", "Patients with sick sinus syndrome", "Patients with progressive sensorineural hearing loss", "Suspected hereditary basis for cardiac or hearing conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: I49.5, H90.3 Clinical summary This test evaluates the CACNA1D gene for pathogenic variants associated with sinoatrial node dysfunction and deafness (SANDD). It identifies genetic mutations linked to specific cardiac and hearing conditions.
TEST-5192 CAPN1 Gene Sequencing (Muscular-Skeletal Disorders) Test This genetic test evaluates the CAPN1 gene for pathogenic variants associated with neuromuscular disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAPN1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Provide a complete clinical history", "Provide family pedigree", "Prior genetic counseling is strongly recommended"] Indications ["Suspected hereditary spastic paraplegia", "Suspected limb-girdle muscular dystrophy", "Diagnostic confirmation of CAPN1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21613-4 ICD-10: G71.0, G11.4 Clinical summary This genetic test evaluates the CAPN1 gene for pathogenic variants associated with neuromuscular disorders.
TEST-4969 CC2D1A Gene Sequencing (Autosomal Recessive Intellectual Disability Type 3, MRT3) Test This test identifies pathogenic variants in the CC2D1A gene associated with Autosomal Recessive Intellectual Disability Type 3 (MRT3).	Whole Blood (EDTA), Extracted DNA, or Finger-Prick Blood Spot (FTA Card)	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CC2D1A gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Suspected diagnosis of Autosomal Recessive Intellectual Disability Type 3 (MRT3)", "Evaluation of developmental delay and intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: F78 Clinical summary This test identifies pathogenic variants in the CC2D1A gene associated with Autosomal Recessive Intellectual Disability Type 3 (MRT3).
TEST-3885 CCDC28B Gene Bardet‑Biedl Syndrome Modifier NGS Test This test identifies pathogenic variants in the CCDC28B gene, a known modifier gene associated with Bardet‑Biedl syndrome.	Whole Blood (peripheral), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC28B gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Mandatory genetic counseling session", "Document clinical history", "Chart pedigree of affected family members"] Indications ["Suspected Bardet‑Biedl syndrome", "Family history of Bardet‑Biedl syndrome", "Evaluation of multi-systemic ciliopathy"] Measurement technique Confirm with laboratory Codes LOINC: 99058-9 ICD-10: Q87.89, Z13.79, Z14.8 Clinical summary This test identifies pathogenic variants in the CCDC28B gene, a known modifier gene associated with Bardet‑Biedl syndrome.
TEST-2235 CCDC8 Gene Sequencing for 3‑M Syndrome Type 3 (NGS) Test This test analyzes the CCDC8 gene for pathogenic variants associated with 3-M syndrome type 3.	Whole Blood (2–3 mL) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC8 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["Prior genetic counselling is mandatory", "Detailed clinical history required"] Indications ["Suspected 3-M syndrome type 3 based on clinical features", "Dysmorphology evaluation", "Genetic counseling for families with suspected 3-M syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 76479-2 ICD-10: Q87.1 Clinical summary This test analyzes the CCDC8 gene for pathogenic variants associated with 3-M syndrome type 3.
TEST-4020 CCM2 Gene Sequencing for Cerebral Cavernous Malformations Type 2 (Genetic Test) This genetic test analyzes the CCM2 gene to identify mutations associated with cerebral cavernous malformations type 2.	Peripheral blood (3–5 mL in EDTA tube), dried blood spot on FTA card, or extracted genomic DNA (≥1 µg at ≥50 ng/µL)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCM2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number alterations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not alter or discontinue prescribed therapy without consulting your physician"] Indications ["Individuals with multiple cavernous malformations on MRI", "Family history of CCM", "First-degree relatives of a proband with a confirmed CCM2 mutation"] Measurement technique Confirm with laboratory Codes LOINC: 92966-6 ICD-10: Q28.3, Z82.3, Z15.89 Clinical summary This genetic test analyzes the CCM2 gene to identify mutations associated with cerebral cavernous malformations type 2.
TEST-3239 CD59 Gene Sequencing (NGS) Genetic Test This test analyzes the CD59 gene to detect pathogenic variants associated with CD59-mediated hemolytic anemia and immune-mediated polyneuropathy.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD59 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation ["Avoid blood transfusion within 4 weeks prior to testing.", "Discuss medication changes with your physician before the test."] Indications ["Suspected CD59 deficiency", "Chronic hemolytic anemia of unknown cause", "Family history of CD59 deficiency", "Evaluation for complement inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 90420-0 ICD-10: D59.8 Clinical summary This test analyzes the CD59 gene to detect pathogenic variants associated with CD59-mediated hemolytic anemia and immune-mediated polyneuropathy.
TEST-4946 CD81 Gene Immunodeficiency Common Variable Type 6 Genetic Test This test identifies pathogenic variants in the CD81 gene associated with Common Variable Immunodeficiency type 6 (CVID6).	Whole blood (EDTA), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CD81 gene", "Single-exon variants", "Copy-number variants"] Parameters [] Preparation [] Indications ["Suspected Common Variable Immunodeficiency type 6 (CVID6)", "Recurrent infections with low immunoglobulin levels"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D83.8 Clinical summary This test identifies pathogenic variants in the CD81 gene associated with Common Variable Immunodeficiency type 6 (CVID6).

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.